Terms: = Head and neck cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
8 results:
1. Erianin Exerts Antineoplastic Effects on Esophageal Squamous Cell Carcinoma Cells by Activating the cgmp-PKG Signaling Pathway.
Deng X; Wu Q; Li D; Liu Y
Nutr Cancer; 2023; 75(6):1473-1484. PubMed ID: 37099024
[TBL] [Abstract] [Full Text] [Related]
2. Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma.
Zhu C; Li J; Yao M; Fang C
BMC Oral Health; 2021 Oct; 21(1):506. PubMed ID: 34625078
[TBL] [Abstract] [Full Text] [Related]
3. STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype.
Della Corte CM; Sen T; Gay CM; Ramkumar K; Diao L; Cardnell RJ; Rodriguez BL; Stewart CA; Papadimitrakopoulou VA; Gibson L; Fradette JJ; Wang Q; Fan Y; Peng DH; Negrao MV; Wistuba II; Fujimoto J; Solis Soto LM; Behrens C; Skoulidis F; Heymach JV; Wang J; Gibbons DL; Byers LA
J Thorac Oncol; 2020 May; 15(5):777-791. PubMed ID: 32068166
[TBL] [Abstract] [Full Text] [Related]
4. KDM5 histone demethylases repress immune response via suppression of STING.
Wu L; Cao J; Cai WL; Lang SM; Horton JR; Jansen DJ; Liu ZZ; Chen JF; Zhang M; Mott BT; Pohida K; Rai G; Kales SC; Henderson MJ; Hu X; Jadhav A; Maloney DJ; Simeonov A; Zhu S; Iwasaki A; Hall MD; Cheng X; Shadel GS; Yan Q
PLoS Biol; 2018 Aug; 16(8):e2006134. PubMed ID: 30080846
[TBL] [Abstract] [Full Text] [Related]
5. Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.
Tuttle TR; Takiar V; Kumar B; Kumar P; Ben-Jonathan N
Cancer Lett; 2017 Mar; 389():33-40. PubMed ID: 28025101
[TBL] [Abstract] [Full Text] [Related]
6. The cyclic gmp/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinoma.
Tuttle TR; Mierzwa ML; Wells SI; Fox SR; Ben-Jonathan N
Cancer Lett; 2016 Jan; 370(2):279-85. PubMed ID: 26551887
[TBL] [Abstract] [Full Text] [Related]
7. Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.
Morita H; Murata T; Shimizu K; Okumura K; Inui M; Tagawa T
Oncol Rep; 2013 Apr; 29(4):1275-84. PubMed ID: 23381931
[TBL] [Abstract] [Full Text] [Related]
8. Outcomes from the first mouth cancer awareness and clinical check-up day in the Dublin Dental University Hospital.
MacCarthy D; Nunn J; Healy CM; Stassen LF; Gorman T; Martin B; Toner M; Clarke M; Dougall A; McLoughlin J; Kelly A; Waldron C; O'Sullivan M; Doyle C; Flint S
J Ir Dent Assoc; 2012; 58(2):101-8. PubMed ID: 22611791
[TBL] [Abstract] [Full Text] [Related]
